| 1 |
33378113 | Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings. | 2021 May 1 |
2 |
| 2 |
31899823 | Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy. | 2020 Mar |
1 |
| 3 |
32610428 | Interleukin-6 and Lymphocyte Count Associated and Predicted the Progression of Frailty Syndrome in Prostate Cancer Patients Undergoing Antiandrogen Therapy. | 2020 Jun 29 |
1 |
| 4 |
31013891 | Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy. | 2019 Apr 13 |
1 |
| 5 |
29288516 | Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression. | 2018 Mar |
1 |
| 6 |
29691294 | Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer. | 2018 Sep 15 |
1 |
| 7 |
27329245 | Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer. | 2017 Jan |
2 |
| 8 |
22213519 | Altered association of interleukin-6 with sex steroids in lipid metabolism disorder in men with prostate cancer receiving androgen deprivation therapy. | 2012 Aug 1 |
2 |
| 9 |
22302227 | Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer. | 2012 |
1 |
| 10 |
22475653 | Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings. | 2012 Oct |
1 |